| 英文别名 |
N-[3-[[2-[[4-(4-Methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide;Olmutinib;HM61713;BI 1482694;HM71224;CHL9B67L95;Olmutinib (HM61713, BI 1482694);N-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide;N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide;Olmutinib [INN];2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-;2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl;Example 1 [US20130116213];N-(3-(2-(4-(4 methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide;AS-74850;N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide;FDMQDKQUTRLUBU-UHFFFAOYSA-N;AC-35418;MFCD29918158;HM 71224;HM 61713;CHEMBL3786343;DS-015877;J-690142;Olmutinib [WHO-DD];OLMUTINIB [USAN];BRD-K60421517-001-01-4;NSC-792848;BI1482694;BI 1482694;BI-1482694;HM 61713;HM-61713;HM61713;BDBM50160871;D10859;UNII-CHL9B67L95;AC-30225;BCP16733;NS00073590;N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide;N-(3-(2-(4-(4-Methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide;CS-5413;N-(3-((2-(4-(4-Methylpiperazin-1-yl)anilino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide;Olmutinib(HM-71224);1802181-20-9;2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-;EX-A879;AKOS030632791;1353550-13-6;N-[3-({2-[4-(4-Methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl}oxy)phenyl]prop-2-enamide;W12116;HM-61713 (BI-1482694);Q27088175;DB13164;Olmutinib [USAN:INN];Olmutinib (HM61713; BI-1482694)?;CCG-269594;HM-61713;GTPL9196;NSC800980;s8294;DTXSID001319119;4-{[4-({[(1R,2S)-2-Phenylcyclopropyl]amino}methyl)-1-piperidinyl]methyl}benzoic acid;SCHEMBL14914931;BI-1482694;Olmutinib (USAN/INN);SB19797;NSC-800980;HY-19730;HM71224;Olmutinib;NSC792848;HM61713, BI 1482694 |